Nimodipine Sustained Release Tablet for Ischemic Cerebtovascular Disease

• Application: Internal Medicine
• Usage Mode: For oral administration
• Suitable for: Adult
• State: Liquid
• Shape: Tablet
• Type: Organic Chemicals
• Model NO.: unapplicable
• Pharmaceutical Technology: Chemical Synthesis
• Drug Reg./Approval No.: H20030026
• Function: Ischemic Cerebtovascular Disease, Migraine
• Product: Nimodipine Sustained Release Tablet
• Transport Package: Carton
• Specification: 60mg
• Trademark: SHUF
• Origin: China
• HS Code: 3004909090
• Production Capacity: 100000 Boxes/Week

Product Description

Nimodipine Sustained Release tablets 

[Indications]
It is used for ischemic cerebrovascular disease, migraine, cerebral vasospasm caused by mild subarachnoid hemorrhage, sudden deafness and mild to moderate hypertension.

[Specification] 60mg (calculated as per C2H, N, O)

[Usage and dosage] Oral administration: 60~120mg (equivalent to 1~2 tablets) - times, twice a day.



For English Packing, please contact with us.